Rezolute, Inc. Common Stock (NV) (RZLT) Stock Price, Quote & AI Analysis
Live RZLT stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Rezolute, Inc. Common Stock (NV).
TradeVae provides AI-driven analysis and real-time market intelligence for Rezolute, Inc. Common Stock (NV) (RZLT), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Rezolute, Inc. Common Stock (NV)'s fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Rezolute, Inc. Common Stock (NV) Overview
Company information
Company Overview
Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism. Its antibody therapy, ersodetug, is designed to treat all forms of hyperinsulinism. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada in March 2010 and is headquartered in Redwood City, CA.
Company Details
Technical Indicators
Key technical analysis metrics and indicators
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Rezolute, Inc. Common Stock (NV) Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...